Doctorpresso to Launch AI-Powered Group Therapy Earbuds at CES 2026

Doctorpresso, a leading AI mental health technology company, will showcase Therapods at CES 2026 in Las Vegas, introducing what it describes as the world's first AI-powered earbuds designed specifically for virtual group therapy sessions. The device utilizes real-time emotion sensing and group interaction analysis technology that could significantly reduce the cost of mental healthcare while maintaining clinical-grade standards.

Therapods integrate advanced artificial intelligence with multimodal biosensing capabilities to monitor voice patterns, brainwaves, and heart rate variability. This comprehensive approach enables the device to deliver real-time emotional insights with more than 90% accuracy, according to company data. A key innovation addresses one of the most significant challenges in virtual mental healthcare: the restoration of critical nonverbal cues that are typically lost in remote therapy sessions.

The global mental health system continues to face substantial challenges, with traditional barriers including cost, stigma, and limited access creating significant gaps in care delivery. Doctorpresso aims to bridge these gaps through Therapods, offering a scalable solution that provides personalized emotional insights while ensuring robust security and privacy protections. The technology has already gained industry recognition, earning finalist status for the 2025 GLOMO Awards at Mobile World Congress.

At CES 2026, attendees will have the opportunity to experience live demonstrations of Therapods' emotion-sensing capabilities and virtual group therapy applications. These demonstrations will highlight the technology's potential to transform digital mental healthcare by making professional-grade emotional support more accessible and affordable. The company, founded with a mission to make healthcare more accessible, develops AI wearables supported by multiple patents and clinical validations.

Doctorpresso has established itself as a leader in digital mental health by combining rigorous scientific validation with intuitive design principles, ensuring both therapeutic effectiveness and user trust. The company's work has been recognized through peer-reviewed studies and global award nominations, with solutions designed not only to support individual users but also to create frameworks for scalable, preventive mental healthcare systems.

Therapods represent a significant advancement in accessible mental health technology, according to Hwanbo Jung, CEO of Doctorpresso. By merging advanced AI with human-centered design, the company aims to break down traditional barriers and bring proactive emotional support to people worldwide. Doctorpresso is actively exploring partnerships with corporations, telemedicine providers, and educational institutions to expand Therapods' reach and impact.

The company's long-term vision involves establishing a preventive mental health ecosystem where emotional wellbeing becomes an integrated part of daily life. At CES 2026, Doctorpresso plans to announce new collaborations and demonstrate how Therapods technology can be adopted across various industries, reinforcing its position as a global innovator in AI-powered healthcare solutions. This development comes at a critical time when mental health services face increasing demand and accessibility challenges worldwide.